ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Quantum Genomics

Quantum Genomics (ALQGC)

0.0721
0.00
(0.00%)
Closed January 18 11:30AM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.0721
Bid
0.0068
Ask
0.065
Volume
0.00
0.00 Day's Range 0.00
0.001 52 Week Range 0.155
Market Cap
Previous Close
0.0721
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
0.00
Shares Outstanding
69,709,954
Dividend Yield
-
PE Ratio
-1.54
Earnings Per Share (EPS)
-0.05
Revenue
36k
Net Profit
-3.17M

About Quantum Genomics

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Paris, Paris, Fra
Founded
-
Quantum Genomics is listed in the Pharmaceutical Preparations sector of the Euronext with ticker ALQGC. The last closing price for Quantum Genomics was 0.07 €. Over the last year, Quantum Genomics shares have traded in a share price range of 0.001 € to 0.155 €.

Quantum Genomics currently has 69,709,954 shares outstanding. The market capitalization of Quantum Genomics is 5.03 € million. Quantum Genomics has a price to earnings ratio (PE ratio) of -1.54.

ALQGC Latest News

Quantum Genomics Announces Lack of Significant Efficacy for Firibastat in Their Phase III Study, FRESH and is Redirecting to New Developments

Firibastat efficacy non-significant versus placeboThe REFRESH study and the development of firibastat in cardiology have been stoppedCash of 11 million euros allotted to the development of new...

Bryan Garnier & Co Initiates the Coverage of Quantum Genomics with a Target Price at 13€ per Share

PARIS, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specialising in the development of a new class of medicinal...

Quantum Genomics Publishes its 2022 First Half Results and Reviews its Activity

PARIS, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specialising in the development of a new class of medicinal...

Quantum Genomics Announces That the Results Obtained with Firibastat in its Phase III Study, FRESH Will Now be Presented on November 7, 2022, During the AHA Conference in a Session Dedicated to Resistant Hypertension

PARIS, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specialising in the development of a new class of medications...

Quantum Genomics announces the appointment of its new Scientific Advisory Board

PARIS, June 27, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specializing in the development of a new drug class directly...

Quantum Genomics Announces the End of Patient Recruitment for its Phase III Pivotal Study FRESH

PARIS, May 09, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specializing in the development of a new drug class directly...

Quantum Genomics Appoints Sarah Merlen Boulenger as Head of Regulatory Affairs

PARIS, May 04, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth : ALQGC, OTCQX : QNNTF), a biopharmaceutical company specializing in the development of a new drug class directly...

Quantum Genomics Publishes its Results for Fiscal Year 2021 and Provides a Corporate Update

PARIS, April 28, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specialising in the development of a new class of medicinal...

Quantum Genomics Announces Successful Capital Raise with a Gross Sum of Approximately 15.6M€

Quantum Genomics has equipped itself with new financial means to pursue the development of firibastat and explore new therapeutic fields based on the patented technology platform built around...

Quantum Genomics Raises a Gross Amount of Approximately € 15 M

Launch of capital increase of approximately €15 million for institutional investors with cancellation of the pre-emptive subscription rightA minimum of €12 million subscription commitments...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.07210.07210.072100DE
4000.07210.07210.072100DE
12000.07210.07210.072100DE
26-0.0279-27.90.10.1380.0017843330.05086068DE
52-0.0293-28.89546351080.10140.1550.0014330680.05705903DE
156-4.1479-98.29146919434.224.4620.0013112720.43808009DE
260-3.4629-97.96039603963.5356.1850.0013052911.7805853DE

ALQGC - Frequently Asked Questions (FAQ)

What is the current Quantum Genomics share price?
The current share price of Quantum Genomics is 0.0721 €
How many Quantum Genomics shares are in issue?
Quantum Genomics has 69,709,954 shares in issue
What is the market cap of Quantum Genomics?
The market capitalisation of Quantum Genomics is EUR 5.03M
What is the 1 year trading range for Quantum Genomics share price?
Quantum Genomics has traded in the range of 0.001 € to 0.155 € during the past year
What is the PE ratio of Quantum Genomics?
The price to earnings ratio of Quantum Genomics is -1.54
What is the cash to sales ratio of Quantum Genomics?
The cash to sales ratio of Quantum Genomics is 140
What is the reporting currency for Quantum Genomics?
Quantum Genomics reports financial results in EUR
What is the latest annual turnover for Quantum Genomics?
The latest annual turnover of Quantum Genomics is EUR 36k
What is the latest annual profit for Quantum Genomics?
The latest annual profit of Quantum Genomics is EUR -3.17M
What is the registered address of Quantum Genomics?
The registered address for Quantum Genomics is 6, RUE CAMBACERES, PARIS, PARIS, 75008
What is the Quantum Genomics website address?
The website address for Quantum Genomics is quantum-genomics.com/societe/
Which industry sector does Quantum Genomics operate in?
Quantum Genomics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
DRVDSDrone Volt
0.0039 €
(3,800.00%)
774.48k
GTRDSGroupe Tera DS
0.0585 €
(800.00%)
3.27k
ALCYBCybergun
0.0002 €
(100.00%)
3.98M
DMSBSDiagnostic Medical Systems
0.0075 €
(87.50%)
129.59k
NICBSNicox SA
0.0265 €
(50.57%)
979
MLSMLSmalto
0.014 €
(-33.33%)
1.62k
ALVERVergnet
0.0015 €
(-21.05%)
97.17M
MLIDSIds
0.364 €
(-19.11%)
1.12k
MCPGrupo Media Capital Sgps Sa
1.62 €
(-19.00%)
3
ALBOOBOOSTHEAT
0.063 €
(-15.78%)
70.91k
ATOAtos SE
0.002 €
(-4.76%)
2.53B
ALVERVergnet
0.0015 €
(-21.05%)
97.17M
BCPBanco Comercial Portugues SA
0.4988 €
(0.79%)
69.25M
EDPEDP SA
3.149 €
(1.22%)
13.56M
VIVVivendi SE
2.546 €
(-1.01%)
8.93M

Discussion

View Full Feed
littlejohn littlejohn 3 minutes ago
Around $33 starts new short squeeze area

now since the 11/15/24 low...

https://www.barchart.com/stocks/quotes/SMCI/interactive-chart

We are at the mercy of the big fundies

that control most of the trading float...

Sadly, ma
SMCI
XMaster2023 XMaster2023 3 minutes ago
RobotDroid you’re working late tonight. Must live in CA.
NWBO
dinogreeves dinogreeves 8 minutes ago
Very odd, the way NBIS and SMC*I trading, however I do understand SMC*I leaving some traders, trading in and out and weary of the time line of the audit report. We have had massive up days with the general market especially today and both were down. This one doesn't get too much coverage with the
NBIS
Jollibee Jollibee 12 minutes ago
Fist time in 2 years I’ve been on this position. Too bad it’s in my Roth IRA so I can’t play with it, but I’ll definitely flip it into either XDTE or YBTC, and take the weekly dividend and not reinvest. Dividend harvesting time, I’m eyeing quantum and evtl stocks for long game plays. And the APPS st
FDCT
AlwaysOptimistic AlwaysOptimistic 13 minutes ago
I also think there is enough room and enough investors dollars out there for all things tech (AI, quantum, bio tech, Fortine 500 and others). Good chance there will be more foreign investment coming in with the change in admins for a more business friendly environment for foreign investment dollars.
IONQ
Dodger1 Dodger1 14 minutes ago
https:/ /www.juliawalck.com/shop/p/the-most-important-meal-art-print
AABB
Dodger1 Dodger1 19 minutes ago
https ://www.juliawalck.com/shop/p/egg-on-your-face-art-print

$AABB
AABB
TightCoil TightCoil 19 minutes ago
We have to be wary of a Release with Conditions -
We must Fight, Fight, Fight For, INSIST ON:

UNCONDITIONAL RELEASE

And until we're guaranteed an Unconditional Release
we must stay Afraid, Very Afraid
FNMA
santafe2 santafe2 19 minutes ago
While all the focus is on tech criminals the real problem may be the crypto Ponzi scheme. They spent reportedly $170MM to get him elected. There's a reason he loves the poorly educated. This is the message heard loud and clear by everyone from banking to investment and, of course, every criminal in
quester614 quester614 23 minutes ago
MovyChem was a SCAM company along with Xeriant SRO. MovyChem EU is gone . No website for either. A company that took 20 years to develop Retacell just disappears. I have shown before that Xeriant SRO & MovyChem were started by Vladimír Bíža who can be tracked back to Aegea Inc/ Futureland SCAM He al
XERI
3331 3331 24 minutes ago
BIEL: HUGE HIT IN TAIWAN!
https://www.actipatchtw.com/general-1
dinogreeves dinogreeves 26 minutes ago
Once they kill all the options by the dead line, this will run. Market makers are begging for mercy they don't report before the deadline, they have probably colluded with the insiders too, it is plausible. The quote below is from someone on Stocktwits. Essentially I am not to only one with commo
SMCI
Werbe Werbe 29 minutes ago
Everyone that posts here start with some extraordinary story of upbringing or some sort of passive social shout.  Anyone a high-school dropout or start from welfare?  
CrypticDomain141 CrypticDomain141 32 minutes ago
I’ve done my research and I’m long.

I don’t understand why everyone is so shocked that this is still volatile at this time. It doesn’t have any revenue yet, and it doesn’t have a big pharm partner….yet.

But from the clinical trials it seems they’ve got the goods. The C
AVXL
Drugdoctor Drugdoctor 35 minutes ago
Here is our CEO's stock chart pattern... Soon we will see $SRNW sporting the same pattern.

https://investorshub.advfn.com/uimage/uploads/2025/1/17/yrkgpGVSI_1-17.png
SRNW
AlwaysOptimistic AlwaysOptimistic 35 minutes ago
I also saw that. Of course Chambers would take that position. He has a lot of capital invested in AI and other tech with his venture funding group (JC2 Ventures) and a lot to lose if investors siphon money away from AI in to quantum. Just like NVDIA. This too shall pass IMO.
IONQ
SSKILLZ1 SSKILLZ1 35 minutes ago
Why Pete would play there now is beyond me. Maybe he has a love of public humiliation?

I have no clue why either. At this point. Which is why I would be shocked if he comes back at this point.

One thing for sure: any Mets solution at first base that includes regularly p
4u2nv2 4u2nv2 35 minutes ago
I have looked at a lot of charts on IFUS. 1M, 1Y, 5Y and I specifically focused on the volume and PPS movement. I did say recently that I am not trading this stock. I do not own any or plan on buying it. I am more focused on a private business model than trading OTC or any stocks. But the IFUS PPS h
IFUS
nowwhat2 nowwhat2 35 minutes ago
Charts are just totally freaking SCREAMING that it COULD be a "Sell The News" Event......and yet ?

It's like.....



https://investorshub.advfn.com/uimage/uploads/2025/1/17/zvqmlxrp_!_17_hyper_845pm_CALVIN_INAUG_PARADE_ATH.jpg



XRPUSD
littlejohn littlejohn 36 minutes ago
SMCI will be at 47 to 48 in a Pop

before we can read the 10K

filing header...

That is why you gotta be ready before

it is filed...

Around $48 is the recent trading high

that market makers marked that may
SMCI
Drugdoctor Drugdoctor 37 minutes ago
Remember, assets from other stock mergers will be added to $FORW's holding company. Right now, something is happening with American Blockchain ($GVSI), our CEO's other shell, and if it is the first to merger, some assets will be coming here. Can't wait for $FORW's chart to look like this.
FORW
MONTANAJOE MONTANAJOE 38 minutes ago
Just amuse each other with their nonsense!
NBRI
TucsonPhil TucsonPhil 38 minutes ago
Wow. According to OTC markets, the OS count is now 5,988,649,454. Last time I checked was last year, and I recall it was around 3.9B, when the AS was 5B, then they raised the AS to 10B and have been busy with quite a bit of dilution.
KGKG
MONTANAJOE MONTANAJOE 38 minutes ago
Like it better when they just talk to each other and leave everyone else alone!!
NBRI
againstallodds againstallodds 40 minutes ago
https://investorshub.advfn.com/uimage/uploads/2025/1/17/rarvyIMG_0265.jpeg

0.5 oz of rhodium per ton of ore can be considered a very high-grade deposit. Here's why:
* Rhodium is extremely rare: It's one of the rarest and most valuable precious metals.
* Typical grades
NBRI